advanced Ovarian Borderline Tumors
Treatment of Advanced-Stage Ovarian Borderline Tumors
TREATMENT READING
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025. Captured 2026-09-09.
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025. Captured 2026-09-09.
Treatment options for early-stage ovarian borderline tumors include:
Surgery.
Sources: Surgery
This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025. Captured 2026-09-09.
In early-stage disease (stage I or II), no additional treatment is indicated for patients with a completely resected borderline tumor.[1]
Sources: 1
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025. Captured 2026-09-09.
The value of complete staging has not been demonstrated for patients with early-stage disease, but the opposite ovary should be carefully evaluated for evidence of bilateral disease. The impact of surgical staging on therapeutic management has not been defined. However, in a study of 29 patients with presumed localized disease, 7 patients were upstaged after complete surgical staging.[2]
Sources: 2
In two other studies, 16% and 18% of patients with presumed localized borderline tumors were upstaged as a result of a staging laparotomy.[3,4] In one of these studies, the yield for serous tumors was 30.8%, compared with 0% for mucinous tumors.[3]
In another study, patients with localized intraperitoneal disease and negative lymph nodes had a low incidence of recurrence (5%), whereas patients with localized intraperitoneal disease and positive lymph nodes had a statistically significant higher incidence of recurrence (50%).[5]
Sources: 5
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025. Captured 2026-09-09.
When a patient wishes to retain childbearing potential, a unilateral salpingo-oophorectomy is adequate therapy.[6,7] In the presence of bilateral ovarian cystic neoplasms, or for patients with a single ovary, a partial oophorectomy can be used to preserve fertility.[8] Some physicians stress the importance of limiting ovarian cystectomy to patients with stage IA disease whose cystectomy specimen margins are tumor free.[9]
In a large series, the relapse rate was higher for patients who underwent more conservative surgery (cystectomy > unilateral oophorectomy > total abdominal hysterectomy and bilateral salpingo-oophorectomy [TAHBSO]). However, differences were not statistically significant, and the survival rates were nearly 100% for all groups.[5,10] When childbearing is not a consideration, a TAHBSO is appropriate therapy. Once a patient's family is complete, most, but not all,[9] physicians favor removal of remaining ovarian tissue as there is risk of recurrence of a borderline tumor or, rarely, a carcinoma.[3,6]
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025. Captured 2026-09-09.
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025. Captured 2026-09-09.
Treatment options for advanced-stage ovarian borderline tumors include:
Surgery.
Sources: Surgery
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025. Captured 2026-09-09.
Patients with advanced disease should undergo a total hysterectomy, bilateral salpingo-oophorectomy, omentectomy, node sampling, and aggressive cytoreductive surgery. Patients with stage III or IV disease with no gross residual tumor had a survival rate of 100% in some series, regardless of the follow-up duration.[1,2] Patients with gross residual disease had a 7-year survival rate of only 69% in a large series, [3] and survival appeared to be inversely proportional to the length of follow-up.[3]
Chemotherapy and/or radiation therapy are not indicated for patients with more advanced-stage disease and microscopic or gross residual disease. Scant evidence exists that postoperative chemotherapy or radiation therapy alters the course of this disease in any beneficial way.[1,3-6] In a retrospective study of 364 patients without residual tumor, adjuvant therapy had no effect on disease-free or corrected survival when stratified for disease stage.[7] Patients without residual tumor who received no adjuvant treatment had a survival rate equal to or greater than the treated groups. No controlled studies have compared postoperative treatment with no postoperative treatment.
In a review of 150 patients with borderline ovarian tumors, the survival of patients with residual tumors smaller than 2 cm was significantly better than survival for those with residual tumors measuring 2 cm to 5 cm or tumors measuring larger than 5 cm (P < .05).[8] It is not clear whether invasive implants imply a worse prognosis. Some investigators have correlated invasive implants with a poor prognosis,[9] while others have not.[2,10] Some studies have suggested DNA ploidy of the tumors can identify patients who will develop aggressive disease.[11,12] One study could not correlate DNA ploidy of the primary serous tumor with patient survival, but found that aneuploid invasive implants were associated with a poor prognosis.[13] No evidence indicates that treating patients with aneuploid tumors would have an impact on survival. No significant associations were found between TP53 and HER2/neu overexpression and tumor recurrence or patient survival.[14]
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
The prognosis and treatment options depend on:
Sources: prognosis
the stage of the disease (whether it affects part of the ovary, involves the whole ovary, or has spread to other places in the body)
Sources: stage
what type of cells make up the tumor
the size of the tumor
the patient's general health
Patients with ovarian borderline tumors have a good prognosis, especially when the tumor is found early.
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
Recurrent ovarian borderline tumors are tumors that have come back after they have been treated. The tumors may come back in the other ovary or in other parts of the body. Tests will be done to help determine where the tumor has returned. The type of treatment for a recurrent ovarian borderline tumor will depend on where it has come back.
Sources: ovary
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
There are different types of treatment for patients with ovarian borderline tumors.
The following types of treatment are used:
The following types of treatment are used:
Surgery
Chemotherapy
New types of treatment are being tested in clinical trials.
Treatment for ovarian borderline tumors may cause side effects.
Follow-up care may be needed.
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
Different types of treatments are available for ovarian borderline tumors. You and your care team will work together to decide your treatment plan, which may include more than one type of treatment. Many factors will be considered, such as the stage of the tumor, your overall health, and your preferences. Your plan will include information about your tumor, the goals of treatment, your treatment options and the possible side effects, and the expected length of treatment.
Talking with your care team before treatment begins about what to expect will be helpful. You'll want to learn what you need to do before treatment begins, how you'll feel while going through it, and what kind of help you will need. To learn more, visit Questions to Ask Your Doctor About Treatment.
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
The type of surgery (removing the tumor in an operation) depends on the size and spread of the tumor and the patient's plans for having children. Surgery may include:
Unilateral salpingo-oophorectomy is surgery to remove one ovary and one fallopian tube.
Sources: Unilateral salpingo-oophorectomy · ovary · fallopian tube
Bilateral salpingo-oophorectomy is surgery to remove both ovaries and both fallopian tubes.
Sources: Bilateral salpingo-oophorectomy
Total hysterectomy and bilateral salpingo-oophorectomy is surgery to remove the uterus, cervix, and both ovaries and fallopian tubes. If the uterus and cervix are taken out through the vagina, the operation is called a vaginal hysterectomy. If the uterus and cervix are taken out through a large incision (cut) in the abdomen, the operation is called a total abdominal hysterectomy. If the uterus and cervix are taken out through a small incision (cut) in the abdomen using a laparoscope, the operation is called a total laparoscopic hysterectomy.
Sources: Total hysterectomy · uterus · cervix · vagina · abdomen · laparoscope
Partial oophorectomy is surgery to remove part of one ovary or part of both ovaries.
Sources: Partial oophorectomy
Omentectomy is surgery to remove the omentum (a tissue layer that lines the abdominal wall).
Sources: Omentectomy · omentum
After the doctor removes all disease that can be seen at the time of the surgery, the patient may be given chemotherapy (also called chemo) after surgery to kill any tumor cells that are left. Treatment given after the surgery to lower the risk that the tumor will come back is called adjuvant therapy.
Sources: adjuvant therapy
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
Chemotherapy uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Chemotherapy for ovarian borderline tumors is usually systemic, meaning it is injected into a vein or given by mouth. When given this way, the drugs enter the bloodstream to reach cancer cells throughout the body.
Learn more about how chemotherapy works, how it is given, common side effects, and more at Chemotherapy to Treat Cancer and Chemotherapy and You: Support for People With Cancer.
Sources: Chemotherapy to Treat Cancer · Chemotherapy and You: Support for People With Cancer
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
For some people, joining a clinical trial may be an option. There are different types of clinical trials for people with cancer. For example, a treatment trial tests new treatments or new ways of using current treatments. Supportive care and palliative care trials look at ways to improve quality of life, especially for those who have side effects from cancer and its treatment.
You can use the clinical trial search to find NCI-supported cancer clinical trials accepting participants. The search allows you to filter trials based on the type of cancer, your age, and where the trials are being done. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.
Sources: clinical trial search · ClinicalTrials.gov
Learn more about clinical trials, including how to find and join one, at Clinical Trials Information for Patients and Caregivers.
Sources: Clinical Trials Information for Patients and Caregivers
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
For information about side effects caused by treatment for cancer, visit our Side Effects page.
Sources: side effects · Side Effects
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
As you go through treatment, you will have follow-up tests or check-ups. Some tests that were done to diagnose or stage the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.
Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back).
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
Surgery is the standard treatment for early stage ovarian borderline tumors. The type of surgery usually depends on whether a patient plans to have children.
Sources: standard treatment · stage
For patients who plan to have children, surgery is either:
unilateral salpingo-oophorectomy or
Sources: unilateral salpingo-oophorectomy
partial oophorectomy
Sources: partial oophorectomy
To prevent recurrence of disease, most doctors recommend surgery to remove the remaining ovarian tissue when a patient no longer plans to have children.
Sources: recurrence
For patients who do not plan to have children, treatment may be hysterectomy and bilateral salpingo-oophorectomy.
Sources: hysterectomy · bilateral salpingo-oophorectomy
Learn more about these treatments in the Treatment Option Overview.
Sources: Treatment Option Overview
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
Treatment for advanced stage ovarian borderline tumors may be hysterectomy, bilateral salpingo-oophorectomy, and omentectomy. A lymph node dissection may also be done. Patients with advanced disease should undergo a total hysterectomy, bilateral salpingo-oophorectomy, omentectomy, node sampling, and aggressive cytoreductive surgery.
Sources: stage · bilateral salpingo-oophorectomy · omentectomy · lymph node dissection · total hysterectomy
Learn more about these treatments in the Treatment Option Overview.
Sources: Treatment Option Overview
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Source: Ovarian Borderline Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025. Captured 2026-09-09.
Treatment for recurrent ovarian borderline tumors may include:
Sources: recurrent
surgery to remove cancer that has spread in the abdominal cavity
surgery followed by chemotherapy
Sources: chemotherapy
Learn more about these treatments in the Treatment Option Overview.
Sources: Treatment Option Overview
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Treatment of Advanced-Stage Ovarian Borderline Tumors
Ovarian Borderline Tumors
Treatment of Recurrent Ovarian Borderline Tumors